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Background: Polyethylenimine (PEI)-based nonviral gene-delivery systems are commonly 
employed because of their high transfection efficiency. However, the toxic nature of PEI is a 
significant obstacle in clinical gene therapy. In this study, we developed biocompatible glycerol 
triacrylate–spermine (GT–SPE) polyspermine as a nanosized gene carrier for potential lung 
cancer gene therapy.
Methods: The GT–SPE was synthesized using the Michael addition reaction between GT 
and SPE. The molecular weight was characterized using gel permeability chromatography 
multiangle laser light scattering and the composition of the polymer was analyzed using proton 
nuclear magnetic resonance.
Results: The GT–SPE successfully protected the DNA from nucleases. The average particle 
size of the GT–SPE was 121 nm with a zeta potential of +23.45 mV . The GT–SPE was found 
to be less toxic than PEI for various cell lines, as well as for a murine model. Finally, our results 
showed that the GT–SPE/small hairpin Akt1 (shAkt1) complex suppressed lung tumorigenesis in 
a K-rasLA1 lung cancer mice model by inducing apoptosis through the Akt signaling pathway and 
cell cycle arrest. Aerosol delivered GT–SPE/shAkt1, which reduced matrix metalloproteinase-9 
activity and suppressed the expression levels of proliferating cell nuclear antigen, as well as 
vascular endothelial growth factors and CD31, which are known proliferation and angiogenesis 
markers, respectively.
Conclusion: Our data suggest that GT–SPE may be a candidate for short hairpin-shaped RNA-
based aerosol lung cancer gene therapy.
Keywords: lung cancer, gene therapy, aerosol delivery, spermine
RNA interference (RNAi) has attracted significant attention in the research of genetic 
disorders and infectious diseases, including cancer, because of its therapeutic effects.1,2 
Transfecting synthetic small interfering RNA (siRNA) or plasmid DNA vectors can 
directly induce RNA interference by expressing short hairpin-shaped RNA (shRNA).3 
Several lines of evidence have demonstrated that shRNA-expressing vectors yielded 
more durable knockdown effects when compared to siRNA.4 Naked shRNA has a 
strong anionic-charged phosphodiester backbone and, as a result, cannot freely cross 
the cellular membrane. Therefore, viral or nonviral delivery systems that facilitate 
c  ellular transfection of shRNA are required.5 In terms of gene delivery, viral vectors are 
very efficient, but they have the potential to cause inadequate DNA-carrying capacity, 
immunogenicity, and mutations in patients.6,7 In contrast, nonviral vectors are stable, 
easy to modify, and have been proven to possess high biocompatibility.8,9 One of the 
nonviral vectors, polyethylenimine (PEI), is a very effective polymer that can be used 
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for gene delivery in any pH condition because of the proton 
sponge effect.10 However, PEI is toxic in nature and is also 
known to stimulate apoptotic pathways.11,12 As an alterna-
tive to nonviral polymer, we have developed polyspermine 
because of its high transfection efficiency with low in vitro 
and in vivo toxicity.
We synthesized biocompatible glycerol triacrylate– 
spermine (GT–SPE) polyspermine using the Michael addition 
reaction and then validated the complex formation between 
polymer and DNA. In addition, we analyzed the toxicity and 
efficiency of transfection both in vitro and in vivo. The   GT–SPE 
was found to be much safer than PEI in both in vitro and in vivo 
studies. The GT–SPE/DNA also showed high transfection 
efficiency. Lastly, the antitumor efficacies of   GT–SPE/shAkt1 
were evaluated using a K-rasLA1 mouse model of non-small 
cell lung cancer (NSCLC). The complex exhibited efficient 
small hairpin Akt1 (shAkt1) delivery and induced apoptosis 
through the Akt signaling pathway and cell cycle arrest.
Materials and methods
Materials
Glycerol triacrylate (GT) (MW: 254 Da), spermine (MW: 
202.34 Da), and anhydrous ethyl alcohol were purchased 
from Sigma-Aldrich (St Louis, MO). pcDNA3.1/CT-GFP 
plasmid (6.1 kb) was purchased from Invitrogen (Carlsbad, 
CA).   pcDNA3.1 plasmids were multiplied in Escherichia coli, 
extracted by alkaline lysis, and purified by a QIAGEN kit 
(QIAGEN, Chatsworth, CA). Luciferase gene, a 5.3 kb pGL3 
expression vector that is driven by an SV40 promoter, enhancer, 
and Cell Titer 96 Aqueous One solution reagent, were pur-
chased from Promega (Madison, WI). Akt1 antibodies were 
purchased from Cell Signaling (Danvers, MA). Bax, Bcl-xL, 
proliferating cell nuclear antigen (PCNA), Cyclin B1, vascular 
endothelial growth factor (VEGF), and Actin   antibodies were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). 
Matrix metalloproteinase-9 (MMP-9) and CD31 antibodies 
were purchased from Abcam (Cambridge, UK).
Preparation of GT–SPE copolymer
GT–SPE copolymer was synthesized using the Michael 
addition reaction. GT (1.5 M) and SPE (2.5 M) were sepa-
rately dissolved in 2 mL of anhydrous ethanol at 4°C, and 
GT solution was slowly stirred into the SPE solution at 
4°C for 2 hours and stored overnight at room temperature. 
Subsequently, the polymer was dialyzed using Spectra/Por® 
membrane (MWCO = 3,500) against distilled water at 4°C 
for 24 hours. Finally, the copolymer was lyophilized and 
stored at -20°C.
Characterizations of copolymer  
and GT–SPE/DNA complexes
The composition of the prepared GT–SPE copolymer was 
estimated by measuring proton nuclear magnetic resonance 
(1H NMR) using AvanceTM 600 spectrometer (Bruker, 
Karlsruhe, Germany). For measurement of NMR, polymers 
were dissolved in D2O at a concentration of 10 mg/mL. 
The GT–SPE polymer molecular weight was measured by 
gel permeability chromatography (GPC) with 690 nm laser 
wavelength (DAWN(R) EOS; Wyatt, Santa Barbara, CA).
All GT–SPE/DNA complexes were freshly prepared 
before use and characterized using the method described 
by Jiang et al.13 Complexes were prepared by adding DNA 
solution to equal volumes of copolymer solution, vortexing 
gently, and incubating at room temperature for 30 minutes. 
The DNA condensation and protection abilities of the 
GT–SPE polymer were confirmed by electrophoresis. The 
morphology of GT–SPE/DNA was observed by using an 
energy-filtering transmission electron microscope (EF-TEM; 
LIBRA 120; Carl Zeiss, Oberkochen, Germany). The size 
(scattering angle: 90°) and surface charge (scattering angle: 
20°) of the GT–SPE complexes were measured at 25°C using 
an electrophoretic light-scattering spectrophotometer (ELS 
8000; Otsuka Electronics, Osaka, Japan).
Cell viability assay and transfection 
efficiency studies of GT–SPE
A549 (human lung carcinoma cells; American Type Culture 
Collection [ATCC], Manassas, VA), HepG2 (human hepa-
toblastoma cells; ATCC), MCF7 (human breast cancer cells; 
ATCC), and 16HBE14o- (human bronchial epithelial cells) 
were cultured in RPMI 1640 (PAA Laboratories, Pashing, 
Austria), Dulbecco’s Modified Eagle Medium (DMEM; 
PAA Laboratories), and DMEM:Nutrient Mixture F-12 
(DMEM/F12; PAA Laboratories), respectively. 16HBE 
14o- cells were kindly provided by Dr Dieter C Gruenert 
(University of California, San Francisco, CA). All of the 
culture media were supplemented with 10% fetal bovine 
serum (FBS; PAA Laboratories), streptomycin (100 µg/mL), 
and penicillin (100 U/mL). All of the cells were incubated at 
37°C in a humidified 5% CO2 atmosphere.
Cell viability and transfection efficiency studies were 
evaluated according to a method reported previously.13 For 
in vitro cytotoxicity tests, cells were seeded in 96-well plates 
at an initial density of 1 × 104 cells/well in 0.2 mL of growth 
medium and incubated for 24 hours in advance of the addi-
tion of the filtered polymers. Growth media were replaced by 
serum-free media containing various amounts of polymers. 
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After additional incubation for 24, 48, and 72 hours, the 
media were substituted for growth media containing 20 µL of 
Cell Titer 96® Aqueous One solution reagent. After additional 
incubation for 3 hours, the absorbance was measured using 
an ELISA plate reader (GLR 1000; Genelabs Diagnostics, 
Singapore). For the cell transfection efficiency study, cells 
were seeded in 24-well plates at an initial density of 1.5 × 105 
cells/well in 1 mL of growth medium. After 18 hours of 
incubation, the media were replaced with serum-free or 
media with polymer/pGL3 (1 µg) complex and additionally 
incubated for 4 hours. Subsequently, the media were replaced 
with fresh media and allowed to incubate for 24 hours at 
37°C. The luciferase assay was performed according to the 
manufacturer’s protocol.
In vivo aerosol delivery study
Six-week-old female BALB/c mice (Breeding and Research 
Center, Seoul National University, Seoul, Korea) were pur-
chased from Joongang Laboratory Animal Inc (Seoul, Korea) 
and used in accordance with the policy and regulations for 
the care and use of laboratory animals as provided by Seoul 
National University, Korea. Animals were kept in the labora-
tory animal facility with temperature and relative humidity 
maintained at 23°C ± 2°C and 50% ± 10%, respectively, and 
with a 12 hour light/dark cycle. Based on previously used 
methods, mice were placed in a nose-only exposure cham-
ber and exposed to the aerosol for gene delivery.3 Twelve 
BALB/c mice were randomly divided into three groups (four 
mice/group). To check the efficiency of GT–SPE as a gene 
carrier, treatment groups were exposed to aerosol containing 
green fluorescent protein (GFP) expression plasmid DNA 
with and without a carrier, and the remaining group was 
used as an untreated control. Mice were sacrificed 2 days 
after exposure and lungs were collected for detection of 
the GFP signal. Lung tissues were fixed at room tempera-
ture and embedded in Tissue-Tek OCT (Sakura, Torrance, 
CA). Ten micrometers of tissue cryosection were cut with 
a microtome (Leica, Nussloch, Germany) and mounted on 
slides for analysis. All the methods used in this study were 
approved by the Animal Care and Use Committee at Seoul 
National University (SNU-101211-3).
Six-week-old female K-rasLA1 mice with human NSCLC 
were obtained from the Human Cancer Consortium-
National Cancer Institute (Frederick, MD) and divided 
into four groups (four mice/group). Mice were exposed 
to aerosol using the method described above and the 
control group mice were left untreated. The other groups 
were exposed to aerosol containing Akt1 shRNA only   
or 4 mg GT–SPE and 0.4 mg DNA (scramble or Akt1 shRNA) 
in distilled water. Treated mice were exposed to aerosol 
twice a week for 4 consecutive weeks. At the end of the exper-
iment, the mice were sacrificed.3 During necropsy, neoplastic 
lesions of the lung surfaces were carefully counted under 
a microscope, following the method described   previously.14 
At the same time, the lungs were perfused with PBS, and a 
lobe of the left lung was collected and fixed in 10% neutral 
buffered formalin for histopathological examination. After 
the experiment, the remaining lungs were stored at -80°C 
for further study.
Western blot analysis
Thirty micrograms of protein was separated by SDS-PAGE 
gel and transferred to nitrocellulose membranes and blocked 
for 1 hour in Tween 20 in Tris-buffered saline (TTBS) 
containing 5% skim milk. Immunoblotting was carried out 
by incubating the membranes overnight with corresponding 
primary antibodies in 5% skim milk at 4°C. The nitrocellu-
lose membrane was then incubated with secondary antibodies 
conjugated to horseradish peroxidase for 3 hours at room 
temperature or overnight at 4°C. After washing, the bands 
were detected by a luminescent image analyzer (LAS-3000; 
Fujifilm, Tokyo, Japan). Quantification of Western blot bands 
analysis was performed by Multi Gauge software (version 
2.02; Fujifilm).
Histopathological analysis
Lung tissues were fixed in 10% neutral buffered formalin, 
paraffin-embedded, and sectioned (4 µm). For histological 
analysis, tissue sections were stained with hematoxylin 
and eosin (H&E). For immunohistochemistry (IHC),   tissue 
sections were deparaffinized in xylene and rehydrated 
in serial alcohol gradients 100% to 50% each for 2 minutes. 
Subsequently, to quench endogenous peroxidase activity, 
slides were washed and incubated in 3% hydrogen peroxide 
(AppliChem, Darmstadt, Germany) for 20 minutes. After 
washing with a TTBS solution, tissue slides were incubated 
with 3% bovine serum albumin (BSA) in TTBS for 1 hour 
at room temperature to block the unspecific binding sites. 
Primary antibodies (dilution of 1:100 in 3% BSA) were 
applied on tissue sections at 4°C overnight. Tissue slides were 
washed and incubated in 3% BSA with secondary horseradish 
peroxide (HRP)-conjugated antibodies   (Invitrogen) (dilution 
of 1:50 in 3% BSA) for 3 hours at room temperature. After 
washing, the slides were reacted with 3,3′-diaminobenzidine 
(DAB) (Biosesang, Sungnam, Korea) with constant observa-
tion under a light microscope and washed with distilled water. 
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Tissue slides were counterstained with hematoxylin (DAKO, 
Carpinteria, CA) and incubated with xylene. Tissue sec-
tions were mounted using cover slips and Permount (Fisher 
Scientific, Waltham, MA) and the slides were reviewed 
using a light microscope (Carl Zeiss, Thornwood, NY). 
  Quantification of staining intensity of PCNA, VEGF, and 
CD31 was performed using InStudio software (version 
3.01; Pixera, San Jose, CA). In randomly selected fields 
viewed with appropriate magnification of objective lens, 
staining intensity was assessed by counting the number of 
positive cells.
Statistical analysis
Data are expressed as mean values ± standard error of 
four experiments. Statistical significances were analyzed 
using Student’s t-test with two populations in Microcal 
Origin software (Microcal Software, Northampton, MA). 
P , 0.05 was considered statistically significant, P , 0.01 
was highly significant, and P , 0.001 was more significant 
when compared with corresponding values. Quantification 
of Western blot analysis was performed using MultiGauge 
software (version 2.02; Fujifilm, Tokyo, Japan).
Results
Synthesis and characterization  
of GT–SPE polyspermine
The GT–SPE was synthesized by the Michael addition reac-
tion between GT and SPE (Figure 1). The composition of 
the complex was confirmed by  1H NMR (Supplementary 
  Figure 1A). The result of GPC multiangle laser light scat-
tering (GPC-MALS) analysis showed that the molecular 
weight of GT–SPE was 4.63 kDa with 1.22 polydispersity 
index (PDI) (Supplementary Figure 1B).
Characterization of GT–SPE/DNA 
complexes
We confirmed the condensation capability of GT–SPE 
polyspermine with DNA complex by agarose gel electro-
phoresis. GT–SPE/DNA complexes were prepared at various 
weight ratios (0.1–10) by mixing polymer solution with plas-
mid DNA. The migration of GT–SPE/DNA complex started 
to be retarded at the weight ratio of 0.5 and was completely 
retarded at the weight ratio of 5 (Supplementary Figure 2A). 
As shown in Supplementary Figure 2B, DNA in the GT–SPE 
complexes was protected from DNase I, however, naked 
plasmid DNA was degraded. GT–SPE/DNA complexes 
had a compact and spherical structure (Supplementary 
  Figure 2C). The complexes were formed around 121 nm 
(PDI: 2.895e-001) and showed relative homogenous size 
distribution as measured by dynamic light scattering (Supple-
mentary   Figure 2D). The zeta potentials of the GT–SPE/DNA 
complexes were positively charged [+23.45 mV , Mobility: 
1.771e-004 (cm2/Vs)] (Supplementary Figure 2E).
Cytotoxicity of GT–SPE
The GT–SPE copolymer showed low cytotoxicity in four dif-
ferent cell lines when compared to PEI 25K   (Supplementary 
Figure 3A–D). GT–SPE copolymer-treated cells showed 
higher cell viability in A549, HepG2, MCF7, and 16HBE14o- 
cell lines than PEI 25K-treated cells.
In vitro transfection studies  
of GT–SPE polyspermine
GT–SPE/DNA showed higher transfection efficiency than 
naked DNA in luciferase reporter gene expression assay. 
However, GT–SPE/DNA showed slightly lower transfection 
efficiency than PEI 25K (Supplementary Figure 4A).
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Figure 1 Synthetic scheme of GT–SPE polyspermine.
Abbreviations: GT, glycerol triacrylate; SPE, spermine; PEA, .
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To further explain the mechanism of transfection, we 
analyzed the buffering capacity of GT–SPE copolymer. 
A549 cells were treated with bafilomycin A1, which 
is an endosome proton pump inhibitor. In the presence 
of bafilomycin A1, GT–SPE/DNA complexes showed 
decreased reporter gene expression levels (Supplementary 
Figure 4B), likewise for PEI 25K. This suggests that the 
GT–SPE-mediated gene transfection was due to a proton 
sponge effect.
In vivo aerosol delivery studies
Based on in vitro increased cellular uptake, high transfec-
tion efficiency, and low cytotoxicity data, we performed 
a GT–SPE gene delivery efficiency test in vivo. The 
GT–SPE/GFP complex showed much higher fluores-
cence intensity compared to the control- and naked 
GFP-treated groups (Figure 2A). In H&E staining, no 
toxicity was observed in the lungs of the GT–SPE/GFP 
group (Figure 2B). Moreover, after aerosol delivery, the 
GFP expression in the lung was dominant compared to 
other organs (Supplementary Figure 5). In addition, there 
was no observed lesion in other tissues in H&E staining 
(Supplementary Figure 6).
Aerosol delivery of Akt1 shRNA  
with GT–SPE suppressed tumorigenesis
Based on the GFP expression study, Akt1 shRNA with 
  GT–SPE polyspermine was delivered to K-rasLA1 lung can-
cer model mice. Aerosol delivery of Akt1 shRNA/GT–SPE 
significantly decreased the tumor numbers (Figure 3A). The 
apparent antitumor effects of GT–SPE/Akt1 shRNA are 
summarized as a graph for better understanding (Figure 3B 
and C). Lung tumor size in GT–SPE/shAkt-delivered mice 
was significantly decreased (n = 4, P , 0.01 compared to 
control, shAkt only, and GT–SPE/Scr) and the numbers of 
tumors measuring over 1 mm tumor were also decreased 
(n = 4, P , 0.05 compared to control; P , 0.01 compared 
to shAkt only; P , 0.001 compared to GT–SPE/Scr). Using 
H&E staining, we also confirmed the tumor suppression 
effect of GT–SPE/shAkt1 (Figure 3D).
Akt1 shRNA with GT–SPE delivery 
induced apoptosis and cell cycle arrest 
and suppressed proliferation
Our results showed that aerosol delivery of GT–SPE/
shAkt1 significantly decreased Akt1 expression level (n = 4, 
GFP
Control Control
GFP
only
GFP
only
GT–SPE
/GFP
GT–SPE
/GFP
H&E staining B A
Figure 2 In vivo gene transfer analysis after aerosol delivery to lungs. (A) Transfection efficiency study: GFP expression analysis (Magnification, 200×). (B) Lung histopathology 
study: H&E staining (Magnification, 200× ; scale bar, 50 µm).
Abbreviations: GFP, green fluorescent protein; GT–SPE, glycerol triacrylate–spermine; H&E, hematoxylin and eosin.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2297
Suppression of lung cancer by biocompatible glycerol triacrylate–spermineInternational Journal of Nanomedicine 2012:7
P , 0.01 compared to control; P , 0.05 compared to shAkt1 
only and GT–SPE/Scr). To determine whether repeated aerosol-
delivered GT–SPE/shAkt1 might induce apoptosis, the expres-
sions of Bcl-xL (one of the antiapoptotic proteins) and Bax (a 
proapoptotic protein) proteins were examined. There was a 
significant decrease in the expression level of Bcl-xL in the 
GT–SPE/shAkt1-delivered group (n = 4, P , 0.01 compared 
to control, shAkt1 only, and GT–SPE/shAkt1). In contrast, 
there was a significant increase in the expression level of Bax 
in the GT–SPE/shAkt1 inhalation group (n = 4, P , 0.01 
compared to control and GT–SPE/Scr; P , 0.001 compared to 
shAkt1 only) (Figure 4A–D). In addition, to examine whether 
aerosol-  delivered GT–SPE/shAkt1 also inhibits the cell cycle, 
we performed a Western blot analysis and observed that the 
level of cyclin B1 protein was significantly decreased in the 
treated group (Figure 5A), as confirmed by densitometric 
analysis (n = 4, P , 0.01 compared to control, shAkt1 only, and 
GT–SPE/Scr) (Figure 5B). To analyze the degree of cell pro-
liferation in tumor tissue, Western blot and IHC analyses were 
performed. In the GT–SPE/shAkt1-delivered group, the expres-
sion level of PCNA was significantly decreased (Figure 5A) 
and it was further confirmed by densitometric analysis (n = 4, 
P , 0.01 compared to control and GT–SPE/Scr; P , 0.05 com-
pared to shAkt1 only) (Figure 5C). IHC data further confirmed 
that delivery of GT–SPE/shAkt1 suppressed the expression of 
PCNA in the lung tumor tissue (Figure 5D).
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Figure 3 Therapeutic efficiency of GT–SPE as an aerosol gene delivery carrier in lung cancer model K-rasLA1 mice. Aerosol delivery of GT–SPE/Akt1 shRNA significantly 
inhibited lung tumor numbers and tumorigenesis. (A) Lung tumor lesions. (B) Total tumor numbers (n = 4, **P , 0.01 compared to shAkt1 only, GT–SPE/Scr, and control). 
(C) Tumor size over 1 mm; tumor numbers (n = 4, *P , 0.05 compared to control; **P , 0.01 compared to shAkt1 only; ***P , 0.001 compared to GT–SPE/Scr). 
(D) Histopathological features (Magnification, 200×).
Abbreviations: GT–SPE, glycerol triacrylate–spermine; MMP-9, matrix metalloprotease-9; PCNA, proliferating cell nuclear antigen; shAkt1, small hairpin Akt1.
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Figure 4 shAkt1 aerosol delivery significantly decreased Akt1 expression level and induced apoptosis. (A) Western blot bands. Statistical analyses of Western blot (B) Akt1, 
(C) Bax, and (D) Bcl-xL. Bands were analyzed by densitometer (n = 4, *P , 0.05, **P , 0.01, and ***P , 0.001 compared to shAkt1 only, GT–SPE/Scr, and control).
Abbreviations: con, control; GT–SPE, glycerol triacrylate–spermine; shAkt1, small hairpin Akt1.
Inhibited angiogenesis, tumor vessel 
density, and decreased MMP-9 activity 
were evident in Akt1 shRNA  
with GT–SPE-delivered group
MMP-9 was examined for the analysis of invasion and 
metastasis of cancer via the destruction of the extracellular 
matrix and membrane. The expression levels of MMP-9 were 
significantly decreased in the GT–SPE/shAkt1-delivered 
group (Figure 6A) and confirmed by densitometric analysis 
(n = 4, P , 0.05 compared to control; P , 0.01 compared to 
shAkt1 only and GT–SPE/Scr) (Figure 6B). For the analysis 
of tumorigenesis, VEGF, which is an important marker for 
tumor progression, was analyzed using Western blot and 
IHC. Our data revealed that the expression levels of VEGF 
were significantly decreased in the GT–SPE/shAkt1-treated 
group (Figure 6A and E) and the results were analyzed using 
densitometric analysis (n = 4, P , 0.01 compared to control 
and GT–SPE/Scr; P , 0.001 compared to shAkt1 only) 
(Figure 6C). To examine tumor vascular density, the CD31 
expression level was analyzed. Our results clearly showed 
decreased expression of CD31 in the shAkt1-delivered 
group as determined by Western blot and IHC analyses 
(n = 4, P , 0.01 compared to control, shAkt1 only, and 
GT–SPE/Scr) (Figure 6D and E).
Discussion
SPE is a tetraamine with two primary and two secondary 
amino groups that are involved in cellular metabolism.15,16 
SPE is a safe endogenous molecule found in all eukaryotic 
cells, but it has low molecular weight and less amine density. 
To overcome this problem, we synthesized polyspermine 
using the Michael addition reaction between acrylate groups 
of GT and amine groups of SPE (Figure 1). The polymer-
ization of SPE with GT to form GT–SPE was confirmed 
by 1H NMR and GPC analysis. In 1H NMR spectrum, the 
peaks for spermine proton (–CH2–CH2–, δ = 1.6–1.8 ppm) 
and peaks for GT proton (–CH2–, δ = 3.8 ppm) were clearly 
visible, indicating successful coupling of SPE molecule with 
GT (Supplementary Figure 1A).
To confirm the condensation capability of GT–SPE, we 
performed gel electrophoresis assay over various weight 
ratios (0.1–10) of GT–SPE/DNA complexes. At the weight 
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ratio of 0.5, initiation of copolymer retardation and DNA 
complex occurred and, at the weight ratio of 5, the migra-
tion of complexes was totally inhibited (Supplementary 
Figure 2A), suggesting that GT–SPE polyspermine was 
completely bound to the DNA. Thus, a GT–SPE/DNA 
weight ratio of 5 was determined for the rest of the study. 
Surface charge measurement indicated that GT–SPE com-
plexes were +23.45 mV in ζ-potential at 5:1 (GT–SPE/
DNA) ratio (Supplementary Figure 2E). A positive charged 
surface is necessary for binding to a negatively charged cell 
membrane.17,19 Consequently, all of these features suggest 
that the newly synthesized GT–SPE carrier is adequate for 
gene delivery.
As high-molecular-weight PEI (25 kDa) is one of the 
most potent polymeric vectors because of its high pH-
buffering capacity of endosomal escape, we compared the 
cytotoxicity and transfection efficiency of GT–SPE with 
PEI 25K. GT–SPE showed lower cytotoxicity than PEI 
25K in four different cell lines: A549, HepG2, MCF7, and 
16HBE14o-   (Supplementary Figure 3A–D). Toxicologically, 
cationic nanoparticles (NPs) are more toxic than their anionic 
  counterparts.20 In addition, there is a different report that states 
that both positively and negatively charged NPs are toxic, with 
the negative NPs evoking a greater response.21 PEI 25K poly-
plex used in this study showed ζ-potential of +39.17 mV in 
N/P ratio of 10 and GT–SPE/DNA polyplex displayed lower 
ζ-potential (+23.45 mV) at a weight ratio of 5. Although the 
mechanism of PEI toxicity is poorly understood, this surface 
charge difference can be one of the main reasons for the 
lower toxicity of GT–SPE. Aggregation of PEI on the cell 
surface, as well as damage of cell membrane function, may 
be another reason of PEI toxicity, because PEI 25K lacks 
degradable linkages. On the other hand, GT–SPE polysper-
mine has biodegradable ester bond linkages and spermine 
is a biogenic tetraamine, which is safe and naturally present 
in eukaryotic cells. Even though GT–SPE showed slightly 
lower transfection efficiency than PEI 25K (Supplementary 
Figure 4A), it showed significantly effective transfection 
capability (higher than 105 RLU/mg protein). High transfec-
tion efficiency of PEI 25K is believed to originate from the 
so-called intrinsic “proton sponge” effect in which partially 
protonated PEI brings in more protons inside the endocytic 
vesicles embedded with ATPase proton pumps. It is accom-
panied by an influx of chloride counter-ions, finally rupturing 
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endocytic vesicles due to higher osmotic pressure.22 Because 
every third atom of PEI is nitrogen, it has a very high density 
of amines, only 15%–20% of which are protonated at physi-
ological pH.23 This unique property makes PEI an extraordi-
narily strong proton sponge.24 In order to determine whether 
the transfection mechanism of GT–SPE is similar to PEI 
25K, we used bafilomycin A1 as an inhibitor of endosomal 
ATPase proton pump.25 When GT–SPE/DNA complex was 
treated with bafilomycin A1, there was a large decrease in 
the transfection efficiency of the complex, as demonstrated in 
PEI 25K (Supplementary Figure 4B). Though SPE itself has 
less amine density, GT–SPE polyspermine acquired enough 
buffering capacity for efficient gene delivery by polymer-
izing of SPE using GT. Therefore, our results suggest that 
GT–SPE polyspermine can be used as a safe and efficient 
biocompatible gene delivery carrier.
Unlike in vitro gene delivery, requisites for successful 
in vivo gene delivery carrier are much more complex. Among 
the various routes for drug delivery, pulmonary delivery 
provides much faster absorption of small molecules, with 
much less metabolism. Furthermore, lung tissue is naturally 
permeable and functions as a non-invasive port for the entry 
of substances into the circulatory system.26 To test the pos-
sibility of inhalation gene therapy of a newly synthesized 
carrier, we first checked the GFP gene transfection efficiency 
of GT–SPE. We delivered GT–SPE/GFP complexes to mice 
and observed fluorescence expressions in the lungs under 
confocal laser scanning microscope (CLSM). The results 
revealed that the GFP signal of GT–SPE/GFP was more 
dominant in the lungs of the treated group than the control 
and the naked GFP groups (Figure 2A and Supplementary 
Figure 5). In H&E staining, no lesion was observed in the 
lung tissues of the GT–SPE/GFP group when compared to the 
control (Figure 2B and Supplementary Figure 6). These data 
propose the potential application of GT–SPE in inhalation 
gene therapy as an efficient and safe carrier system.
We also tested the therapeutic efficacy of repeated aerosol 
delivery of therapeutic gene to the lung cancer mouse model, 
because repeated gene delivery may cause toxicity with 
incomplete efficacy.27 Furthermore, the majority of airway 
epithelial cells are slowly dividing or terminally differenti-
ated, thus, necessitating the test of repeated administration 
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of gene transfer vectors for long transgenic expression.28 We 
targeted Akt1 as a gene to be downregulated because about 
90% of NSCLC is associated with constitutive activation of 
Akt pathway.29 Furthermore, a previous study has shown that 
aerosol delivery of shAkt1 with polymer carrier can suppress 
the tumorigenesis.3 In this regard, we delivered GT–SPE/
shAkt1 complexes to the lung of the K-rasLA1 lung cancer 
mouse model. Akt pathway regulates Bcl-2 family mem-
bers and apoptotic activity,30 thus, inhibition of Akt1 with 
  GT–SPE by repeated aerosol shAkt1 deliveries may facilitate 
apoptosis. The expression level of proapoptotic protein Bax 
was significantly increased, whereas expression level of 
antiapoptotic protein Bcl-xL was significantly decreased in 
shAkt1 with GT–SPE repeated delivery group when com-
pared to the other groups (Figure 4). These results showed 
that GT–SPE/shAkt1 successfully suppressed tumorigenesis 
through the blockage of Akt signaling pathways and induced 
apoptosis, which was confirmed by total tumor numbers, 
histopathology, and Western blot data (Figures 3 and 4).
The degrees of cell cycle protein and proliferation were 
examined with respect to tumor progression. In higher 
eukaryotes, cyclin B1 and A2 are required for the comple-
tion of the G2/M transition phase.31 In cancers, mutations of 
proteins that regulate progression are frequent; it can lead to 
abnormal cell cycle transition control.32 Our data revealed that 
expression levels of cyclin B1 were significantly decreased 
in the treated group (Figure 5A and B). This means that 
repeatedly delivered GT–SPE/shAkt1 played an important 
role in cell cycle inhibition and it showed similar changes 
with respect to Akt1 expression level (Figures 4A and 5A). 
Phosphatidyl inositol 3-kinase (PI3K)/Akt pathway has a 
critical impact on cell growth, proliferation, and regula-
tion of the cell cycle.33 PCNA is a cell nucleus antigen that 
is expressed during DNA synthesis.34 Aerosol-delivered 
  GT–SPE/shAkt1 significantly decreased the expression level 
of PCNA in lung tumor tissues, which was confirmed by 
Western blot and IHC (Figure 5A–D). In lung tumor tissues, 
cell proliferations were also suppressed in the treated group 
by repeated and efficient shAkt1 deliveries.
MMPs functions in basal membrane and extracellular 
matrix destructions and are associated with the metastasis of 
tumors.35 In addition, MMP-9 expression is highly related to 
metastasis in lung, liver, and breast carcinomas.36 For these 
reasons, MMP-9 expression levels were examined by Western 
blot. Our data showed significantly decreased expression lev-
els of MMP-9 in the GT–SPE/shAkt1 repeated delivery group. 
VEGF is an essential cytokine associated with stimulating 
endothelial cell growth and angiogenesis.37 The expression 
levels of VEGF were also examined using Western blot and 
IHC. CD31 is an endothelial antigen and vasculature marker 
and it can be used to determine the density of intratumoral 
vessels and the degree of neoangiogenesis.38 Significantly 
lower expression levels of VEGF and CD31 were revealed 
by Western blot analysis and low intensities at IHC in the 
repeated delivery group (Figure 6A–D). It was concluded that 
decreased expression of MMP-9, VEGF, and CD31 in the 
GT–SPE/shAkt1-delivered group showed significant inhibi-
tion of metastasis through repeated inhalation   treatments. The 
result of this study may only show preliminary characteris-
tics because obtained data were based on a limited number 
of animals (four per group), therefore, future experiments 
are necessary to clarify the efficiency of GT–SPE for gene 
delivery. These studies are currently underway.
Conclusion
In this study, we have described the successful preparation 
of a novel polyspermine, GT–SPE polymer, and evaluated 
the possibility of its use as a new gene carrier for lung cancer 
gene therapy. The GT–SPE copolymer showed a significant 
ability to form complexes with DNA and possessed suitable 
physicochemical properties as a gene delivery carrier system. 
This copolymer had low cytotoxicity and showed enhanced 
gene transfer efficiency both in vitro and in vivo. Aerosol 
delivery of GT–SPE/shAkt1 significantly suppressed lung 
tumorigenesis through apoptosis with no organ toxicity. 
Therefore, GT–SPE has the potential to serve as a biocom-
patible and efficient aerosol gene carrier system.
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Figure S3 Cytotoxicity of GT–SPE copolymer at various concentrations in different cell lines. (A) A549, (B) HepG2, (C) MCF7, and (D) 16HBE14o- (mean ± SD, n = 3).
Abbreviations: GT–SPE, glycerol triacrylate–spermine; PEI, polyethylenimine; SD, standard deviation.
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Figure S5 In vivo GFP analysis in different organs after aerosol administration.
Abbreviations: GFP, green fluorescent protein; GT–SPE, glycerol triacrylate–spermine.
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Figure S6 In vivo H&E staining in different organs after aerosol administration (magnification: 200×).
Abbreviations: GFP, green fluorescent protein; GT–SPE, glycerol triacrylate–spermine; H&E, hematoxylin and eosin.
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